Oncology

Latest News

Analyzed by birth cohort, the authors found each successive birth cohort had a 7.7% decline in SCLC rates. | Image credit: shidlovski
Decline in SCLC Incidence Expected to Accelerate Through 2050

June 29th 2025

The incidence of small cell lung cancer (SCLC) is projected to drop by 5.9% each year through 2050.

While elevated NLR previously served as a marker of aggressive disease and poor prognosis in SCLC, its prognostic relevance appears to diminish in the context of immunotherapy-based treatment regimens. | Image credit: Crystal light - stock.adobe.com
Challenging the Prognostic Role of NLR in SCLC in the Era of Immunotherapy

June 27th 2025

Gender rights | Image Credit: © Nadzeya-stock.adobe.com
Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care

June 23rd 2025

AJMC Q&A with Coral Omene, MD, PhD | Background image credit: ipopba - stock.adobe.com
Addressing Cancer Care Challenges for Patients, and Ensuring Equity: Coral Omene, MD, PhD

June 22nd 2025

Patients with SCLC in the tarlatamab group had significantly longer overall survival, with a median of 13.6 months vs 8.3 months in the chemotherapy group. | Image credit: mi_viri - stock.adobe.com
Tarlatamab Improves SCLC Outcomes After Platinum Chemotherapy

June 19th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
July 1st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 1st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Overcoming Challenges to Value-Based Care Implementation: Grant Andres
November 10th 2023

Overcoming Challenges to Value-Based Care Implementation: Grant Andres

Rose McNulty
In an interview with The American Journal of Managed Care®, Grant Andres, BSc, DC, BSN, MSN-RN, senior director of clinical operations at Arizona Oncology, discussed the nuances of successfully implementing value-based care initiatives across a large organization.
dr amy laughlin
November 2nd 2023

Dr Amy Laughlin on the Benefits of At-Home Cancer Care

Brooke McCormick
Amy Laughlin, MD, MSHP, of Orlando Health gave a preview of the topic she is presenting on at today's American Journal of Managed Care®’s Institute for Value-Based Medicine® event in New York City.
dr kathi mooney
November 1st 2023

Dr Kathi Mooney Previews Oncology Hospital at Home Presentation

Brooke McCormick
Kathi Mooney, PhD, RN, FAAN, of the University of Utah, gave a preview of "The Oncology Hospital at Home," the presentation she is giving at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on November 2 in New York City.
dr saira jan
October 30th 2023

Dr Saira Jan Details Current, Future Cost Savings From Oncology Therapeutics Home Infusion Program

Brooke McCormick
Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, discussed cost savings that occurred so far from their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health and also noted those they predict to occur as the program continues.
IVBM logo | Image credit: AJMC
October 27th 2023

Collaboration Is Key to Execute Value-Based Care for Patients With Cancer

Rose McNulty
Coverage of the Institute for Value-Based Medicine session with Zangmeister Cancer Center, Columbus, Ohio.
dr saira jan
October 27th 2023

Dr Saira Jan Explains Oncology Therapeutics Home Infusion Pilot Program

Brooke McCormick
Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, provides an overview of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health, discussing the program's origin, objectives, and beyond.
IVBM logo | Image credit: AJMC
October 26th 2023

Multiple Perspectives of Managing Cancer From the Multidisciplinary Team at Vanderbilt

Laura Joszt, MA
Coverage from the Institute for Value-Based Medicine event with Vanderbilt University Medical Center.
IVBM logo | Image credit: AJMC
October 26th 2023

Raising the Bar for Precision Oncology and Clinical Research in a Community Practice Setting

Mary Caffrey
Coverage from the Institute for Value-Based Medicine session with Florida Cancer Specialists & Research Institute.
SAP logo | image credit: AJMC
October 25th 2023

Business Highlights From Partners in Community Oncology

AJMC Staff
OneOncology Finalizes 25 Clinical Pathways in Oncology and Hematology
October 25th 2023

OneOncology Finalizes 25 Clinical Pathways in Oncology and Hematology

AJMC Staff
COA logo | image credit: COA
October 25th 2023

COA’s Policy Agenda Gains Steam on Capitol Hill, as the House Elects a Speaker

Mary Caffrey
There is bipartisan support in the Congress for the Community Oncology Alliance's (COA) key agenda items, with hope that some will pass by year’s end.
Ted Okon, MBA, Community Oncology Alliance
October 25th 2023

Innovating Community Oncology Care Delivery and Payment Reform: Insights From COA’s Ted Okon

Maggie L. Shaw
Ted Okon, MBA, executive director, Community Oncology Alliance, discusses early returns from the Enhancing Oncology Model and how community oncology practices are innovating in ways that can expand into other areas of medicine.
Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic
October 24th 2023

Dr Miriam J. Atkins: Each One of Us Needs Everyone Else

Maggie L. Shaw
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance, discusses the challenges facing oncology today, such as physician and nurse recruitment and minority clinical trial enrollment.
Lalan Wilfongd, MD, US Oncology Network
October 23rd 2023

Dr Lalan Wilfong: Patients Deserve the Full Benefit of Everything We Can Provide

Maggie L. Shaw
At the 2023 COA Payer Exchange Summit being held October 23-24 in Reston, Virginia, Lalan Wilfong, MD, US Oncology Network, emphasizes the importance of oncology care equity, ensuring continuity of care, and enhancing care coordination.
Stomach cancer art | Image credit: Crystal light - stock.adobe.com
October 20th 2023

Frontline Pembrolizumab Plus Trastuzumab/Chemotherapy Improves PFS in HER2+ Gastric/GEJ Cancer

Ryan Scott
Adding pembrolizumab to combination of trastuzumab and chemotherapy improved progression-free survival vs placebo plus trastuzumab and chemotherapy in the first-line treatment of patients with metastatic HER2-positive gastric or gastroesophageal junction (GEJ) cancer.
noted Joelle Hicks, BSN, RN | Image Credit: Summa Health
October 17th 2023

Streamlined Referral Intervention Sees Great Success Among Patients With Head/Neck Cancer

Maggie L. Shaw
A 2022 yearlong initiative at Summa Health Cancer Institute saw 100% of its patients with head and neck cancer undergoing radiation treatment referred to an oncology dietician for nutritional support and/or speech and swallow therapy.
Surgery | Image credit: Surgery_Gorodenkoff - stock.adobe.com.jpeg
October 13th 2023

Treating Hepatobiliary Cancer With Transplant, Resection, or Radiation

Laura Joszt, MA
Knowledge of the different treatment options available and the eligibility criteria for each will help identify the right treatment for patients with hepatobiliary cancer.
Updated Survey: NCCN Centers Say Chemo Shortage Has Ebbed Only Slightly
October 6th 2023

Updated Survey: NCCN Centers Say Chemo Shortage Has Ebbed Only Slightly

Mary Caffrey
The survey, completed over 2 weeks in September, follows a similar one released in June.
AJMC
September 14th 2023

Characteristics of Self-Triaged Emergency Department Visits by Adults With Cancer

Arthur S. Hong, MD, MPH Amy Hughes, PhD D. Mark Courtney, MD, MSCI Hannah Fullington, MPH Simon J. Craddock Lee, PhD, MPH John W. Sweetenham, MD Navid Sadeghi, MD, MSPH Song Zhang, PhD Angela Bazzell, DNP, APRN, FNP-BC, AOCNP Ethan A. Halm, MD, MPH, MBA
Adults with cancer may have difficulty self-assessing the clinical severity of their acute care needs, yet they rarely use a telephone triage line available to them.
AJMC
September 11th 2023

Comparison of Primary Payer in Cancer Registry and Discharge Data

Youngmin Kwon, BA Marcelo C. Perraillon, PhD Coleman Drake, PhD Bruce L. Jacobs, MD, MPH Cathy J. Bradley, PhD Lindsay M. Sabik, PhD
Enrollment in managed care among Medicaid enrollees presents challenges to classifying Medicaid coverage in cancer registries.
Dr Carmen C. Solórzano
August 28th 2023

Dr Carmen Solórzano Explains VICC’s Tumor Boards, Implementing Patient Preferences

Brooke McCormick
Carmen Solórzano, MD, FACS, of Vanderbilt University Medical Center, discusses how Vanderbilt-Ingram Cancer Center (VICC) conducts tumor boards and explains how patient preferences are considered during them.
chemotherapy IV bag
August 24th 2023

Contributor: Grappling With Ongoing Cancer Drug Shortages

Melody Chang, RPh, MBA, BCOP
In 2023, the United States was in the midst of the largest drug shortage in a decade, including lifesaving platinum-based medications to treat a variety of cancers.
Crystal Denlinger
August 23rd 2023

As Incoming CEO, Dr Crystal Denlinger Highlights NCCN Guidelines, Challenges, and Treatment Access

Mary Caffrey Hayden E. Klein
Crystal Denlinger, MD, FACP, incoming CEO of the National Comprehensive Cancer Network (NCCN), talks about the organization’s challenges and solutions to keeping up with the ever-changing oncology landscape and improving patient access to guideline-recommended treatments.
Denlinger
August 23rd 2023

A Mission to Cure “All the Cancers”: Crystal Denlinger, MD, FACP, Named CEO of NCCN

Mary Caffrey
Denlinger, who spent most of her career at Fox Chase Cancer Center before joining the National Comprehensive Cancer Network (NCCN) as its chief scientific officer, took the helm October 9, 2023.
Gustavo Fonseca, MD, FACP, Florida Cancer Specialists & Research Institute
August 19th 2023

Dr Gustavo Fonseca on Key Takeaways From an FCS Analysis on Clinical Trial Enrollment

Pearl Steinzor
Gustavo Fonseca, MD, FACP, physician director of clinical research, Florida Cancer Specialists & Research Institute (FCS), discusses the results from a late phase complexity analysis on barriers to clinical trials regarding biopsy requirements.
Once a Patient, Digital Health Leader Shares How Texas Oncology Invests in Improved Experiences
August 18th 2023

Once a Patient, Digital Health Leader Shares How Texas Oncology Invests in Improved Experiences

Pearl Steinzor
Coverage from the June 8, 2023, Institute for Value-Based Medicine session in Austin, Texas, held in partnership with Texas Oncology.
IVBM LOGO
August 18th 2023

How Does Policy Affect Cancer Care at the Practice Level? Texas Oncology Event Offers Insights

Mary Caffrey
Coverage from the June 8, 2023, Institute for Value-Based Medicine session in Austin, Texas, held in partnership with Texas Oncology.
increasing value in line graph
August 16th 2023

Early-Onset Cancer Incidence in the US Increased Through 2010s

Hayden E. Klein
New research demonstrated varying trends in early-onset cancer incidence based on race, sex, age, and cancer type.
WWR Logo
August 11th 2023

What We're Reading: Chemotherapy Shortage Struggles; Suicide All-Time High; Acid Reflux Drug, Dementia Link

AJMC Staff
One in 3 hospitals report issues with chemotherapy drug shortages; the suicide rate in the United States hit an all-time high in 2022; an acid reflux medication may be linked with higher risk of dementia.
Survival Rates Show Disparities Among Patients with Second Primary Cancer
August 9th 2023

Survival Rates Show Racial Disparities Among Patients With Second Primary Cancers

Giuliana Grossi
Even after adjustments, the underlying trends in disparities persisted, underscoring the significance of survival disparities among second primary cancer survivors.
<1
...
8910111213141516
...
186>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo